Dr. Ping Li focuses her practice on biotechnological, pharmaceutical, and chemical patents involving nanoparticle and macromolecule drugs, small molecule antiviral and anticancer therapies, polymer technology, chemical engineering, and paper technology. In addition to patent drafting, prosecution, opposition, and appeal proceedings, Ping has particular experience in matters relating to supplementary protection certificates (SPCs) including assisting and advising clients on obtaining SPCs and creating SPC portfolios in Europe. She also has experience in IP due diligence, freedom-to-operate analysis, and patent validity opinion and has been involved in German as well as cross-border patent infringement and revocation proceedings. Ping joined Jones Day in May 2008.
Ping is a chemist and a structural biologist by training with technical experience in organic and inorganic synthesis, NMR spectroscopy, molecular biology, protein crystallography, protein expression and purification, RNA biochemistry, virology, antibody, chromatography, mass spectroscopy, electron microscopy, and radioactive labeling. Her doctoral work at the Max Planck Institute for Biophysical Chemistry led to several peer-reviewed publications including a first author publication in the journal Science in 2007. Ping's scientific background allows her to quickly grasp the essence of inventions relating to a broad spectrum of technological fields.
Ping is a member of the Institute of Professional Representatives before the European Patent Office (epi), the German Patent Bar Association, the International Federation of Intellectual Property Attorneys, and the German Association for the Protection of Intellectual Property (GRUR).
Legislative Intent Trumps Legitimate Interest: EPO Confirms Double Patenting as a Ground for Refusal
- December 13, 2021
Women in IP Speaker Series: Artificial Intelligence in the Biopharma Lifecycle: U.S. and EU IP Considerations
- June 6, 2019
Successful claim strategies for inventions arising from product development and emerging technologies: US v. EP, AbbVie IP Day 2019
- September 16, 2015
Opposition Proceedings at the EPO Webinar
- European Qualifying Examination (2013); German Patent Bar Exam (2013); Georg-August-University Göttingen and Max Planck Institute for Biophysical Chemistry, Göttingen, Germany (Dr. rer. nat. with summa cum laude for thesis 2007); University of Canterbury, Christchurch, New Zealand (B.Sc. in Chemistry with first class honors 2002); Uppsala University, Sweden (Exchange student in chemistry, 2001)
- European Patent Office (EPO), German Patent and Trademark Office (GPTO), German Federal Patent Court (BPatG), German Federal Supreme Court (BGH) in nullity appeal proceedings, German Federal Office for Plant Varieties (BSA), International Bureau of WIPO (IB), and Office for Harmonization in the Internal Market (OHIM, European Community Trademarks and Designs)
- Internship with the District Court of Mannheim, German Patent and Trademark Office, and German Federal Patent Court (2012-2013)
- Chinese, English, German, and French